Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUS.
| Author | |
|---|---|
| Abstract |
:
To evaluate the efficacy and safety of ranibizumab 0.5 mg in adult patients with macular edema (ME) resulting from any cause other than diabetes, retinal vein occlusion, or neovascular age-related macular degeneration. |
| Year of Publication |
:
2018
|
| Journal |
:
Ophthalmology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0161-6420
|
| DOI |
:
10.1016/j.ophtha.2017.12.002
|
| Short Title |
:
Ophthalmology
|
| Download citation |
